| GST-HG171 / Fujian Cosunter |
ChiCTR2200067088: A International Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II/III Clinical Study to Evaluate the Efficacy and Safety of GST-HG171/Ritonavir in Patients With Mild to Moderate COVID-19 |
|
|
| Recruiting | 2/3 | 1200 | | GST-HG171 tablets combined with ritonavir ;Placebo | The First Affiliated Hospital of Guangzhou Medical University; The Third People's Hospital of Shenzhen; The First Affiliated Hospital of Guangzhou Medical University, Fujian Akeylink Biotechnology Co., Ltd. | mild to moderate COVID-19 | | | | |
NCT05656443: Study of GST-HG171/Ritonavir Compared With Placebo in Patients With Mild to Moderate COVID-19 |
|
|
| Completed | 2/3 | 1246 | RoW | GST-HG171/Ritonavir, Placebo | Fujian Akeylink Biotechnology Co., Ltd. | COVID-19 Pneumonia | 05/23 | 07/23 | | |
NCT05668897: Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on GST-HG171 Tablets |
|
|
| Completed | 1 | 78 | RoW | GST-HG171, placebo of GST-HG171 | Fujian Akeylink Biotechnology Co., Ltd. | COVID-19 | 12/22 | 12/22 | | |
| Completed | 1 | 24 | RoW | GST-HG171 Tablets | Fujian Akeylink Biotechnology Co., Ltd. | COVID-19 Pneumonia | 02/23 | 05/23 | | |
NCT06084507: Food Effects of GST-HG171 Tablets Combined With Ritonavir in Healthy Chinese Participants |
|
|
| Active, not recruiting | 1 | 18 | RoW | GST-HG171/ritonavir, ritonavir | Fujian Akeylink Biotechnology Co., Ltd. | COVID-19 Respiratory Infection | 05/23 | 12/23 | | |
NCT06087055: Drug-Drug Interaction Study of Itraconazole With GST-HG171/Ritonavir in Healthy Participants |
|
|
| Completed | 1 | 12 | RoW | GST-HG171/Ritonavir, Itraconazole | Fujian Akeylink Biotechnology Co., Ltd. | Healthy Participant | 06/23 | 08/23 | | |
ChiCTR2200067137: A randomized, controlled clinical study to evaluate the efficacy and safety of GST-HG171 tablets in combination with ritonavir in adult subjects with mild/moderate COVID-19 |
|
|
| Recruiting | N/A | 60 | | GST-HG171 tablets combined with ritonavir ;Placebo ;Paxlovid | The First Affiliated Hospital of Guangzhou Medical University; The Third People's Hospital of Shenzhen; The First Affiliated Hospital of Guangzhou Medical University, Fujian Akeylink Biotechnology Co., Ltd. | SARS-CoV-2 infection | | | | |
| Recruiting | N/A | 32 | RoW | GST-HG171 Tablets | Fujian Akeylink Biotechnology Co., Ltd. | COVID-19 Pneumonia | 02/24 | 03/24 | | |
